For example, CRISPRi testing suggested that NTRK1 over-expression can cause AD-like neuronal loss (Tian et al., 2019; Gomez-Isla et al., 1997; Mukhin et al., 2017). This evidence concerns the gene NTRK1 and Alzheimer disease.